Vanda Pharmaceuticals (VNDA) Adopts Limited Duration Stockholder Rights Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.54 -0.03 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.57 | 52 Week High | $18.00 | |||
| Open | $4.56 | 52 Week Low | $6.91 | |||
| Day High | $4.56 | P/E | N/A | |||
| Day Low | $4.48 | EPS | $-0.67 | |||
| Volume | 519,681 | |||||
